Supplementary Figure and Table — Comparative Outcomes Across Rituximab Induction Doses in Pemphigus

These materials are provided as Supplemental Material for the article “Comparative Outcomes Across Rituximab Induction Doses in Pemphigus: A Real-World Single-Center Study”. Supplementary Figure 1. Time to Complete Response and Relapse Among Groups. (A) The time for achieving complete response (CR) in the groups. (B) The time for achieving relapse in the groups. Supplementary table 1. The detailed information of 53 patients.本材料为论文《天疱疮（Pemphigus）患者利妥昔单抗（Rituximab）诱导剂量的对比结局：一项真实世界单中心研究》的补充资料。 补充图1 各组完全缓解达标时间与复发情况。(A) 各组达到完全缓解（complete response, CR）的时间；(B) 各组出现复发的时间。 补充表1 53例患者的详细临床资料。